ProShare Advisors’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-721
| Closed | -$10.5K | – | 2084 |
|
|
2024
Q2 | $10.5K | Sell |
721
-246
| -25% | -$3.59K | ﹤0.01% | 1834 |
|
|
2024
Q1 | $21.7K | Buy |
967
+153
| +19% | +$3.43K | ﹤0.01% | 1969 |
|
|
2023
Q4 | $15.4K | Buy |
814
+175
| +27% | +$3.31K | ﹤0.01% | 1932 |
|
|
2023
Q3 | $10.9K | Hold |
639
| – | – | ﹤0.01% | 1803 |
|
|
2023
Q2 | $19.2K | Buy |
+639
| New | +$19.2K | ﹤0.01% | 1835 |
|
|
2022
Q2 | – | Sell |
-929
| Closed | -$42K | – | 1867 |
|
|
2022
Q1 | $42K | Sell |
929
-63
| -6% | -$2.85K | ﹤0.01% | 2125 |
|
|
2021
Q4 | $38K | Buy |
992
+410
| +70% | +$15.7K | ﹤0.01% | 2311 |
|
|
2021
Q3 | $30K | Sell |
582
-596
| -51% | -$30.7K | ﹤0.01% | 1989 |
|
|
2021
Q2 | $103K | Buy |
+1,178
| New | +$103K | ﹤0.01% | 2289 |
|